PUBLISHER: KBV Research | PRODUCT CODE: 1431407
PUBLISHER: KBV Research | PRODUCT CODE: 1431407
LAMEA Pharmaceutical Drug Delivery Market Size, Share & Trends Analysis Report By Route of Administration, By Application (Respiratory & Other Diseases, Cancer, Diabetes, and Cardiovascular Diseases), By Country and Growth Forecast, 2023 - 2030
The Latin America, Middle East and Africa Pharmaceutical Drug Delivery Market would witness market growth of 6.2% CAGR during the forecast period (2023-2030).
The prevalence of cardiovascular diseases has led to a growing emphasis on remote patient monitoring and digital health solutions. Digital technologies integrated with drug delivery systems enable real-time vital signs, medication adherence, and cardiovascular health monitoring. Smart devices, such as connected pillboxes and wearable sensors, contribute to a holistic approach to cardiovascular care, enhancing communication between patients and healthcare providers. Heart failure is a common and serious consequence of cardiovascular diseases. Drug delivery innovations are particularly important in treating heart failure, where medications must be carefully titrated to optimize cardiac function. Implantable drug delivery devices and continuous infusion systems are explored to provide sustained and controlled release of medications for heart failure management.
Nanoparticle-based drug delivery systems are gaining prominence for improving drug solubility, enhancing bioavailability, and enabling targeted delivery to specific cells or tissues. Nanomedicine applications include cancer therapy, where nanoparticles can selectively deliver drugs to tumor sites, reducing side effects on healthy tissues. The integration of digital technologies with drug delivery systems is transforming patient care. Smart devices, connected health platforms, and mobile apps enhance medication adherence, provide real-time monitoring, and facilitate communication between patients and healthcare providers. Digital inhalers, smart pill bottles, and wearable devices contribute to a more comprehensive and data-driven approach to healthcare.
As per the National Library of Medicine, the Middle East has a high rate of cardiovascular disease (10.1%). In this region, the prevalence of dyslipidemia (43.3%) is double that of hypertension (26.2%) and diabetes mellitus (16%). Multifaceted interventions are desperately needed in this region for CVD primary prevention. The Middle East is experiencing a notable increase in the prevalence of cardiovascular diseases, including conditions like coronary artery disease, hypertension, and heart failure. Thus, due to these aspects, the pharmaceutical drug delivery market will expand across the LAMEA region in upcoming years.
The Brazil market dominated the LAMEA Pharmaceutical Drug Delivery Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $41 Billion by 2030. The Argentina market is showcasing a CAGR of 6.6% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 5.9% during (2023 - 2030).
Based on Route of Administration, the market is segmented into Injectable Drug Delivery, Oral Drug Delivery, Topical Drug Delivery, Nasal Drug Delivery, and Ocular Drug Delivery. Based on Application, the market is segmented into Respiratory & Other Diseases, Cancer, Diabetes, and Cardiovascular Diseases. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- GlaxoSmithKline PLC (GSK)
- F. Hoffmann-La Roche Ltd.
- Bayer AG
- Pfizer, Inc.
- Johnson & Johnson
- Novartis AG
- Amgen, Inc.
- Sanofi S.A.
- Cipla Limited
- Merck & Co., Inc.
LAMEA Pharmaceutical Drug Delivery Market Report Segmentation
By Route of Administration
- Injectable Drug Delivery
- Oral Drug Delivery
- Topical Drug Delivery
- Nasal Drug Delivery
- Ocular Drug Delivery
By Application
- Respiratory & Other Diseases
- Cancer
- Diabetes
- Cardiovascular Diseases
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA Pharmaceutical Drug Delivery Market, by Route of Administration
- 1.4.2 LAMEA Pharmaceutical Drug Delivery Market, by Application
- 1.4.3 LAMEA Pharmaceutical Drug Delivery Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Opportunities
- 3.2.3 Market Restraints
- 3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
- 4.1 KBV Cardinal Matrix
- 4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.2.4 Geographical Expansions
- 4.2.5 Trials & Approvals
- 4.3 Top Winning Strategies
- 4.3.1 Key Leading Strategies: Percentage Distribution (2021-2024)
- 4.3.2 Key Strategic Move: (Mergers & Acquisition: 2021, Aug - 2023, Oct) Leading Players
- 4.4 Porter's Five Forces Analysis
Chapter 5. LAMEA Pharmaceutical Drug Delivery Market, by Route of Administration
- 5.1 LAMEA Injectable Drug Delivery Market, by Country
- 5.2 LAMEA Oral Drug Delivery Market, by Country
- 5.3 LAMEA Topical Drug Delivery Market, by Country
- 5.4 LAMEA Nasal Drug Delivery Market, by Country
- 5.5 LAMEA Ocular Drug Delivery Market, by Country
Chapter 6. LAMEA Pharmaceutical Drug Delivery Market, by Application
- 6.1 LAMEA Respiratory & Other Diseases Market, by Country
- 6.2 LAMEA Cancer Market, by Country
- 6.3 LAMEA Diabetes Market, by Country
- 6.4 LAMEA Cardiovascular Diseases Market, by Country
Chapter 7. LAMEA Pharmaceutical Drug Delivery Market, by Country
- 7.1 Brazil Pharmaceutical Drug Delivery Market
- 7.1.1 Brazil Pharmaceutical Drug Delivery Market, by Route of Administration
- 7.1.2 Brazil Pharmaceutical Drug Delivery Market, by Application
- 7.2 Argentina Pharmaceutical Drug Delivery Market
- 7.2.1 Argentina Pharmaceutical Drug Delivery Market, by Route of Administration
- 7.2.2 Argentina Pharmaceutical Drug Delivery Market, by Application
- 7.3 UAE Pharmaceutical Drug Delivery Market
- 7.3.1 UAE Pharmaceutical Drug Delivery Market, by Route of Administration
- 7.3.2 UAE Pharmaceutical Drug Delivery Market, by Application
- 7.4 Saudi Arabia Pharmaceutical Drug Delivery Market
- 7.4.1 Saudi Arabia Pharmaceutical Drug Delivery Market, by Route of Administration
- 7.4.2 Saudi Arabia Pharmaceutical Drug Delivery Market, by Application
- 7.5 South Africa Pharmaceutical Drug Delivery Market
- 7.5.1 South Africa Pharmaceutical Drug Delivery Market, by Route of Administration
- 7.5.2 South Africa Pharmaceutical Drug Delivery Market, by Application
- 7.6 Nigeria Pharmaceutical Drug Delivery Market
- 7.6.1 Nigeria Pharmaceutical Drug Delivery Market, by Route of Administration
- 7.6.2 Nigeria Pharmaceutical Drug Delivery Market, by Application
- 7.7 Rest of LAMEA Pharmaceutical Drug Delivery Market
- 7.7.1 Rest of LAMEA Pharmaceutical Drug Delivery Market, by Route of Administration
- 7.7.2 Rest of LAMEA Pharmaceutical Drug Delivery Market, by Application
Chapter 8. Company Profiles
- 8.1 GlaxoSmithKline PLC (GSK)
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Regional Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 Recent strategies and developments:
- 8.1.5.1 Partnerships, Collaborations, and Agreements:
- 8.1.5.2 Product Launches and Product Expansions:
- 8.1.5.3 Acquisition and Mergers:
- 8.1.6 SWOT Analysis
- 8.2 F. Hoffmann-La Roche Ltd.
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 Recent strategies and developments:
- 8.2.5.1 Partnerships, Collaborations, and Agreements:
- 8.2.5.2 Trials & Approvals:
- 8.2.6 SWOT Analysis
- 8.3 Bayer AG
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental and Regional Analysis
- 8.3.4 Research & Development Expense
- 8.3.5 Recent strategies and developments:
- 8.3.5.1 Product Launches and Product Expansions:
- 8.3.5.2 Acquisition and Mergers:
- 8.3.5.3 Geographical Expansions:
- 8.3.6 SWOT Analysis
- 8.4 Pfizer, Inc.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional & Segmental Analysis
- 8.4.4 Research & Development Expense
- 8.4.5 Recent strategies and developments:
- 8.4.5.1 Acquisition and Mergers:
- 8.4.6 SWOT Analysis
- 8.5 Johnson & Johnson
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Segmental & Regional Analysis
- 8.5.4 Research & Development Expenses
- 8.5.5 Recent strategies and developments:
- 8.5.5.1 Partnerships, Collaborations, and Agreements:
- 8.5.5.2 Acquisition and Mergers:
- 8.5.6 SWOT Analysis
- 8.6 Novartis AG
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Segmental and Regional Analysis
- 8.6.4 Research & Development Expense
- 8.6.5 Recent strategies and developments:
- 8.6.5.1 Partnerships, Collaborations, and Agreements:
- 8.6.5.2 Acquisition and Mergers:
- 8.6.6 SWOT Analysis
- 8.7 Amgen, Inc.
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Regional Analysis
- 8.7.4 Research & Development Expenses
- 8.7.5 Recent strategies and developments:
- 8.7.5.1 Acquisition and Mergers:
- 8.7.6 SWOT Analysis
- 8.8 Sanofi S.A.
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Segmental and Regional Analysis
- 8.8.4 Research & Development Expense
- 8.8.5 Recent strategies and developments:
- 8.8.5.1 Partnerships, Collaborations, and Agreements:
- 8.8.5.2 Acquisition and Mergers:
- 8.8.6 SWOT Analysis
- 8.9 Cipla Limited
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Segmental and Regional Analysis
- 8.9.4 Research & Development Expense
- 8.9.5 Recent strategies and developments:
- 8.9.5.1 Partnerships, Collaborations, and Agreements:
- 8.9.6 SWOT Analysis
- 8.10. Merck & Co., Inc.
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Segmental and Regional Analysis
- 8.10.4 Research & Development Expenses
- 8.10.5 Recent strategies and developments:
- 8.10.5.1 Partnerships, Collaborations, and Agreements:
- 8.10.6 SWOT Analysis
LIST OF TABLES
- TABLE 1 LAMEA Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
- TABLE 2 LAMEA Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
- TABLE 3 Partnerships, Collaborations and Agreements- Pharmaceutical Drug Delivery Market
- TABLE 4 Product Launches And Product Expansions- Pharmaceutical Drug Delivery Market
- TABLE 5 Acquisition and Mergers- Pharmaceutical Drug Delivery Market
- TABLE 6 Geographical expansions- Pharmaceutical Drug Delivery Market
- TABLE 7 Trials & Approvals- Pharmaceutical Drug Delivery Market
- TABLE 8 LAMEA Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
- TABLE 9 LAMEA Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
- TABLE 10 LAMEA Injectable Drug Delivery Market, by Country, 2019 - 2022, USD Billion
- TABLE 11 LAMEA Injectable Drug Delivery Market, by Country, 2023 - 2030, USD Billion
- TABLE 12 LAMEA Oral Drug Delivery Market, by Country, 2019 - 2022, USD Billion
- TABLE 13 LAMEA Oral Drug Delivery Market, by Country, 2023 - 2030, USD Billion
- TABLE 14 LAMEA Topical Drug Delivery Market, by Country, 2019 - 2022, USD Billion
- TABLE 15 LAMEA Topical Drug Delivery Market, by Country, 2023 - 2030, USD Billion
- TABLE 16 LAMEA Nasal Drug Delivery Market, by Country, 2019 - 2022, USD Billion
- TABLE 17 LAMEA Nasal Drug Delivery Market, by Country, 2023 - 2030, USD Billion
- TABLE 18 LAMEA Ocular Drug Delivery Market, by Country, 2019 - 2022, USD Billion
- TABLE 19 LAMEA Ocular Drug Delivery Market, by Country, 2023 - 2030, USD Billion
- TABLE 20 LAMEA Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
- TABLE 21 LAMEA Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
- TABLE 22 LAMEA Respiratory & Other Diseases Market, by Country, 2019 - 2022, USD Billion
- TABLE 23 LAMEA Respiratory & Other Diseases Market, by Country, 2023 - 2030, USD Billion
- TABLE 24 LAMEA Cancer Market, by Country, 2019 - 2022, USD Billion
- TABLE 25 LAMEA Cancer Market, by Country, 2023 - 2030, USD Billion
- TABLE 26 LAMEA Diabetes Market, by Country, 2019 - 2022, USD Billion
- TABLE 27 LAMEA Diabetes Market, by Country, 2023 - 2030, USD Billion
- TABLE 28 LAMEA Cardiovascular Diseases Market, by Country, 2019 - 2022, USD Billion
- TABLE 29 LAMEA Cardiovascular Diseases Market, by Country, 2023 - 2030, USD Billion
- TABLE 30 LAMEA Pharmaceutical Drug Delivery Market, by Country, 2019 - 2022, USD Billion
- TABLE 31 LAMEA Pharmaceutical Drug Delivery Market, by Country, 2023 - 2030, USD Billion
- TABLE 32 Brazil Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
- TABLE 33 Brazil Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
- TABLE 34 Brazil Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
- TABLE 35 Brazil Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
- TABLE 36 Brazil Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
- TABLE 37 Brazil Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
- TABLE 38 Argentina Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
- TABLE 39 Argentina Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
- TABLE 40 Argentina Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
- TABLE 41 Argentina Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
- TABLE 42 Argentina Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
- TABLE 43 Argentina Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
- TABLE 44 UAE Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
- TABLE 45 UAE Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
- TABLE 46 UAE Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
- TABLE 47 UAE Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
- TABLE 48 UAE Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
- TABLE 49 UAE Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
- TABLE 50 Saudi Arabia Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
- TABLE 51 Saudi Arabia Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
- TABLE 52 Saudi Arabia Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
- TABLE 53 Saudi Arabia Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
- TABLE 54 Saudi Arabia Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
- TABLE 55 Saudi Arabia Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
- TABLE 56 South Africa Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
- TABLE 57 South Africa Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
- TABLE 58 South Africa Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
- TABLE 59 South Africa Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
- TABLE 60 South Africa Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
- TABLE 61 South Africa Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
- TABLE 62 Nigeria Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
- TABLE 63 Nigeria Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
- TABLE 64 Nigeria Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
- TABLE 65 Nigeria Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
- TABLE 66 Nigeria Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
- TABLE 67 Nigeria Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
- TABLE 68 Rest of LAMEA Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
- TABLE 69 Rest of LAMEA Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
- TABLE 70 Rest of LAMEA Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
- TABLE 71 Rest of LAMEA Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
- TABLE 72 Rest of LAMEA Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
- TABLE 73 Rest of LAMEA Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
- TABLE 74 Key Information - GlaxoSmithKline PLC
- TABLE 75 Key Information - F. Hoffmann-La Roche Ltd.
- TABLE 76 Key Information - Bayer AG
- TABLE 77 Key Information - Pfizer, Inc.
- TABLE 78 Key Information - Johnson & Johnson
- TABLE 79 Key Information - Novartis AG
- TABLE 80 Key Information - Amgen, Inc.
- TABLE 81 Key Information - Sanofi S.A.
- TABLE 82 Key Information - Cipla Limited
- TABLE 83 Key Information - Merck & Co., Inc.
